Skip to content
Monday, 16 November 2026Malta edition Enquire Malta-24 Briefing @CDNewsDispatch
Malta's world news feed Local perspective with global outlook
CDE.NEWS The Dispatch
USA

Pfizer, Moderna vaccines reduce COVID-19 infection risk by 90% after second dose -U.S. study

epa08945393 A doctor finishes inoculating Herri Rehfeld, 92, against COVID-19 at the vaccine center at the Messe Berlin trade fair grounds on the center's opening day during the second wave of the coronavirus pandemic, Berlin, Germany, 18 January 2021. The center is the third to open in Berlin. Three more are to open in coming weeks once shipments of the Pfizer/BioNTech and Moderna vaccines pick up pace. EPA-EFE/SEAN GALLUP / POOL

The COVID-19 vaccines developed by Pfizer Inc with BioNTech SE and Moderna Inc are highly effective and reduced the risk of infection by 90% by two weeks after the second shot among healthcare personnel and first responders, according to a the U.S. study released on Monday.

The findings from a study by the U.S. Centers for Disease Control and Prevention of the real-world use of these messenger RNA (mRNA) vaccines confirm what was seen in large controlled clinical trials conducted before they received emergency use authorizations from the U.S. Food and Drug Administration.

(Reporting by Ankur Banerjee and Vishwadha Chander in Bengaluru; Editing by Bill Berkrot)

Filed under CoronavirusUSA
Topics Moderna

More from USA

More →